Nvidia, Meta, Revolution Medicines, Abercrombie, Intuit, Salesforce, Moderna, and more stocks that explain today’s market

Meta Platforms agrees to pay $18 billion to settle a lawsuit over its social media practices.
Blockonomi

Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment

Revolution Medicines (RVMD) stock gained after the FDA granted early approval to Rasonque for pancreatic cancer, with trial ...
pharmaphorum

Revolution's ASCO showstopper gets FDA greenlight

Revolution Medicines' Rasonque (daraxonrasib), the RAS inhibitor that received a standing ovation at ASCO for its doubling of overall survival in patients with metastatic pancreatic ductal ...

Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.

Detailed price information for Revolution Medicines Inc (RVMD-Q) from The Globe and Mail including charting and trades.
NAI500

Billionaire Loads Up on Revolution Medicines, the Upside Could Be More Than 7%

Stanley Druckenmiller’s investment legend, marked by three decades without a single losing year, speaks to his keen insight into market trends. While Wall Street analysts remain cautious on ...